Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 63305

17 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
September 26, 2012
Product types
Drug
Classifications
Class I and Class II
Statuses
Terminated
Recalling firm wording
New England Compounding Center

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

17 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 17

Methylprednisolone Acetate (PF) 80 mg/ml Injection, supplied in 1 mL, 2 mL and 5 mL vials, manufactured by New England Compounding Center, Framingham, MA

D-108-2013
Recall number
D-108-2013
Initiated
September 26, 2012
Classification
Class I
Status
Terminated
Quantity
23,897 vials

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Non-Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Non-Sterility

Code information

All Lot codes

Distribution pattern

Nationwide

drug · product 2 of 17

Methylprednisolone Acetate (PF) 40 mg/ml Injection, supplied in 1 mL, 2 mL and 5 mL vials, manufactured by New England Compounding Center, Framingham, MA

D-109-2013
Recall number
D-109-2013
Initiated
September 26, 2012
Classification
Class I
Status
Terminated
Quantity
9062 vials

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Non-Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Non-Sterility

Code information

All lot codes

Distribution pattern

Nationwide

drug · product 3 of 17

Methylprednisolone Acetate 40 mg/mL Injection, Preserved, supplied in 5 mL and 10 mL vials, manufactured by New England Compounding Center, Framingham, MA

D-110-2013
Recall number
D-110-2013
Initiated
September 26, 2012
Classification
Class I
Status
Terminated
Quantity
5130 vials

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Non-Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Non-Sterility

Code information

All lot codes

Distribution pattern

Nationwide

drug · product 4 of 17

Methylprednisolone Acetate 80 mg/mL Injection, Preserved, supplied in 5 mL and 10 mL vials, manufactured by New England Compounding Center, Framingham, MA

D-111-2013
Recall number
D-111-2013
Initiated
September 26, 2012
Classification
Class I
Status
Terminated
Quantity
3822 vials

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Non-Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Non-Sterility

Code information

All lot codes

Distribution pattern

Nationwide

drug · product 5 of 17

Betamethasone Repository 6 mg/mL PF Injection and Betamethasone Repository 6 mg/mL P Injection, manufactured by New England Compounding Center, Framingham, MA

D-112-2013
Recall number
D-112-2013
Initiated
September 26, 2012
Classification
Class II
Status
Terminated
Quantity
N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lot codes

Distribution pattern

Nationwide

drug · product 6 of 17

Betamethasone Sodium Phosphate 6 mg/mL P Injection, Betamethasone Sodium Phosphate 6 mg/mL PF Injection, Betamethasone Sodium Phosphate 8 mg/mL PF Injection, Betamethasone Sodium Phosphate 12 mg/mL PF Injection, manufactured by New England Compounding Center, Framingham, MA

D-113-2013
Recall number
D-113-2013
Initiated
September 26, 2012
Classification
Class II
Status
Terminated
Quantity
N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lot codes

Distribution pattern

Nationwide

drug · product 7 of 17

Bupivacaine 0.25% PF, Bupivacaine 0.5% PF, and Bupivacaine 0.75% PF, manufactured by New England Compounding Center, Framingham, MA

D-114-2013
Recall number
D-114-2013
Initiated
September 26, 2012
Classification
Class II
Status
Terminated
Quantity
N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lot codes

Distribution pattern

Nationwide

drug · product 8 of 17

Clonidine 100 mcg/mL PF, 1mL and 2 mL vials, manufactured by New England Compounding Center, Framingham, MA

D-115-2013
Recall number
D-115-2013
Initiated
September 26, 2012
Classification
Class II
Status
Terminated
Quantity
2747 vials

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lot codes

Distribution pattern

Nationwide

drug · product 9 of 17

Dexamethasone Sodium Phosphate 4 mg/mL vials PF, 6 mg/mL PF vials, and 8 mg/mL PF vials, manufactured by New England Compounding Center, Framingham, MA

D-116-2013
Recall number
D-116-2013
Initiated
September 26, 2012
Classification
Class II
Status
Terminated
Quantity
20 vials

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lot codes

Distribution pattern

Nationwide

drug · product 10 of 17

Glycerin 100% PF, 1mL, 2 mL, and 5 mL vials, manufactured by New England Compounding Center, Framingham, MA

D-117-2013
Recall number
D-117-2013
Initiated
September 26, 2012
Classification
Class II
Status
Terminated
Quantity
165 vials

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lot codes

Distribution pattern

Nationwide

drug · product 11 of 17

Hyaluronidase 150 u/ml PF, 1 mL, 5 mL, and 10 mL vials, manufactured by New England Compounding Center, Framingham, MA

D-118-2013
Recall number
D-118-2013
Initiated
September 26, 2012
Classification
Class II
Status
Terminated
Quantity
10,865 vials

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lot codes

Distribution pattern

Nationwide

drug · product 12 of 17

Isovue 200 mg/mL PF and 300 mg/mL PF, Vials, manufactured by New England Compounding Center, Framingham, MA

D-119-2013
Recall number
D-119-2013
Initiated
September 26, 2012
Classification
Class II
Status
Terminated
Quantity
7055 vials

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lot codes

Distribution pattern

Nationwide

drug · product 13 of 17

Lidocaine/Dextrose 5%/7.5% PF, manufactured by New England Compounding Center, Framingham, MA

D-120-2013
Recall number
D-120-2013
Initiated
September 26, 2012
Classification
Class II
Status
Terminated
Quantity
N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lot codes

Distribution pattern

Nationwide

drug · product 14 of 17

Lidocaine 1% PF, 2% PF, and 4% PF, in 1 mL, 2 mL, 5 mL, and 10 mL vials, manufactured by New England Compounding Center, Framingham, MA

D-121-2013
Recall number
D-121-2013
Initiated
September 26, 2012
Classification
Class II
Status
Terminated
Quantity
3,321 vials

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lot codes

Distribution pattern

Nationwide

drug · product 15 of 17

Omnipaque 240mg/mL PF, 300mg/mL PF, in 3 mL, 5 mL, and 10 mL, vials, manufactured by New England Compounding Center, Framingham, MA

D-122-2013
Recall number
D-122-2013
Initiated
September 26, 2012
Classification
Class II
Status
Terminated
Quantity
8919 vials

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lot codes

Distribution pattern

Nationwide

drug · product 16 of 17

Saline 10% and 3%, in 5 mL and 10 mL vials, manufactured by New England Compounding Center, Framingham, MA

D-123-2013
Recall number
D-123-2013
Initiated
September 26, 2012
Classification
Class II
Status
Terminated
Quantity
54 vials

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lot codes

Distribution pattern

Nationwide

drug · product 17 of 17

Triamcinolone 10 mg/mL P, 40mg/mL P, 40mg/mL PF and 80 mg/mL PF in 1 mL, 2 mL, 5 mL, and 10 mL vials, manufactured by New England Compounding Center, Framingham, MA

D-124-2013
Recall number
D-124-2013
Initiated
September 26, 2012
Classification
Class II
Status
Terminated
Quantity
56,655 vials

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lot codes

Distribution pattern

Nationwide